OCD's Origins Might Not Lie in The Brain Like We Thought
That makes any fresh insight into OCD's root causes especially valuable – like a new study pointing to a surprising suspect: the bacteria living in our gut.
The research from China explored how the gut microbiota – the complex community of bacteria that live in the digestive system – may influence whether a person develops OCD, and identified six types of bacteria that appear to be linked with the condition.
A steady stream of studies has shown close connections between the brain and the gut, but this is the first to provide compelling evidence that gut bacteria may actually help cause it. The researchers used genetic data to strengthen the case for causation.
Related:
"Previous studies have indicated a potential link between the gut microbiota and OCD," write the researchers from Chongqing Medical University in their published paper. "However, the exact causal relationship remains uncertain."
"Our analysis suggested that specific gut microbiota might have a causal relationship with OCD, revealing potential intervention strategies for the prevention and treatment of this disorder."
To explore this link, the researchers used a genetic approach known as Mendelian randomization, which allows scientists to infer causality by analyzing genetic variants that influence both OCD and gut bacteria.
They assessed links between genetic data and gut bacteria in a sample of 18,340 people, and the links between genetic data and OCD in a separate sample of 199,169 people.
Although these were two discrete sets of data, the study used Mendelian randomization to essentially bridge the gap and connect gut bacteria patterns with OCD.
Because our genes are fixed at birth and not shaped by environment or lifestyle, this method helps strengthen the case that gut bacteria might directly contribute to OCD, rather than just being an effect of it.
However, more data and more controlled experiments will be needed to confirm a causal link.
Three types of bacteria appeared to be protective against OCD: Proteobacteria, Ruminococcaceae, and Bilophila. Another three seemed to increase the risk of OCD: Bacillales, Eubacterium, and Lachnospiraceae UCG001.
Interestingly, many of these bacteria have been linked with the brain before. For example, previous studies have found a connection between low levels of Ruminococcaceae species and depression. These findings expand what we already know about the gut-brain axis and how one can affect the other.
"Future research should employ longitudinal designs and diverse populations to validate and expand upon these findings, as well as a more in-depth classification of microbes and their metabolic products, to further understand the role of gut microbiota in OCD," write the researchers.
Down the line – and it's still a way off – we may have a new way to treat or prevent OCD, by controlling gut bacteria mixtures. For people living with the condition – and the families, friends, and clinicians who support them – this could eventually offer new hope.
"Despite the utilization of cognitive behavioral therapy and selective serotonin reuptake inhibitors in OCD treatment, a notable 25–40 percent of patients experience suboptimal or no response to these interventions," write the researchers.
"Moreover, the personal and societal toll of OCD is substantial."
The research has been published in the Journal of Affective Disorders.
The News Cycle Is a Stress Monster. But There's a Healthy Way to Stay Informed.
Surprise Discovery About Sugar in The Brain Could Help Fight Alzheimer's
Air Pollution 'Strongly Associated' With DNA Mutations Tied to Lung Cancer
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
China Kindergartners Battle High Lead Levels From School Meals
More than 200 children from a Chinese kindergarten had 'abnormal' levels of lead in their blood after eating food provided by the school that contained painting pigments, state media reported Tuesday, the latest food safety scare in the country. Only 18 students of the 251 tested at the school in Tianshui, a city in northwestern Gansu province, had normal lead levels, according to the report, which cited investigation results published by the local government.
Yahoo
3 hours ago
- Yahoo
Verified Clinical Trials Launches in Japan in Partnership with Medical Revolutions Japan (MRJ) and JACIC to Prevent Duplicate and Professional Subjects in Clinical Trials
TOKYO & GARDEN CITY, N.Y., July 08, 2025--(BUSINESS WIRE)--Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, has officially launched operations in Japan through a collaboration with Medical Revolutions Japan (MRJ) and the Japan Association of Contract Institutes for Clinical Pharmacology (JACIC) to address the growing global challenge of duplicate and professional research subjects in clinical trials. For the past thirty years, Japan's only system for preventing duplicate subject registration was developed by JACIC and used across Phase 1 studies. However, a recent review concluded that the system requires substantial modernization to meet international standards and support the growing number of global clinical trials. In addition, duplicate subjects in clinical trials have become a growing concern in Phase II and Phase III trials as well. After extensive evaluation, the VCT platform—widely adopted as the global standard—was selected as the best solution and replacement. With the support of MRJ, which was commissioned by JACIC to assist with domestic implementation, Verified Clinical Trials has begun initiating sites in Japan, with additional sites expected to join in the coming weeks and months. These sites will benefit from the biometric capabilities of the VCT system, offering a higher level of subject authentication and protocol compliance. This rollout will include sites conducting Phase I through Phase IV clinical trials. "Given the sophisticated functionality and biometric identification capability of the VCT system, as well as its proven match for other Asian countries," a representative of MRJ commented, "I believe it is destined to become the new Japan standard for duplicate subject registration prevention." Verified Clinical Trials brings to Japan a cross-sponsor, cross-therapeutic area subject registry already in use in up to 40 countries. The platform not only detects but also prevents duplicate subjects and other protocol violations at the time of screening—and maintains protections throughout the entire duration of the trial. "We're honored to bring VCT to Japan as part of a shared mission to raise the standard of subject protection and trial integrity," said Mitchell Efros, MD, President and CEO of Verified Clinical Trials. "No clinical trial or geography is immune to the challenge of duplicate subjects—it's a global phenomenon. Our system provides an effective, scalable solution." "By introducing VCT in Japan, sponsors gain a real-time tool to proactively manage protocol risk and ensure only qualified participants are enrolled," added Kerri Weingard, ANP, Vice President and Chief Operating Officer of Verified Clinical Trials. "This launch represents our commitment to regulatory excellence and regional partnership across the APAC region," said Eve Hsu, Global Regulatory Director at Verified Clinical Trials. "With dedicated team members based throughout APAC, we're well-positioned to support sites and sponsors locally and help elevate clinical trial quality and compliance across the region." The VCT system was co-founded by Mitchell Efros, MD, and Kerri Weingard, ANP, both experienced clinical researchers who developed the registry to address long-standing challenges in subject eligibility, data quality, and compliance. About Verified Clinical Trials (VCT)Verified Clinical Trials is the world's largest research subject database registry designed to detect and prevent duplicate and professional subjects in clinical trials. VCT fills a critical gap in the clinical research industry by providing insight into a research subject's past trial participation. This enables better subject selection and helps ensure successful clinical trial execution. Active in up to 40 countries, VCT supports sponsors, CROs, and research sites across all trial phases and therapeutic areas, enhancing data quality, subject safety, and protocol compliance. About Medical Revolutions Japan (MRJ)Medical Revolutions Japan is a clinical trial consultancy managed and staffed by industry experts with long and rich experience in all facets of clinical development and research in the Japanese market. Founded in 2024 as an affiliate of Keikokai Medical Corporation, a longstanding clinical research unit operator in Tokyo, MRJ is currently expanding its global client base and working to connect both international and local players to help the domestic Japanese clinical development industry rise to the challenges brought about by technological disruptions as it continues to grow and internationalize. View source version on Contacts For media inquiries, please contact:connect@ Sign in to access your portfolio
Forbes
3 hours ago
- Forbes
Workplace Well-Being Isn't Working—Here's What To Do Instead
Sammy Rubin is the founder and CEO of YuLife, the lifestyle insurance company providing life insurance, well-being and rewards in one app. We're living through a paradox. More and more employers are investing in well-being, and yet stress, burnout and disengagement are higher than ever. What went wrong? Flexible hours. Mindfulness apps. Gym memberships. Mental health webinars. These are all well-intentioned initiatives, and yet the results often don't match the investment. Gallup reports that only 21% of employees in 2024 felt engaged at work. Mental health-related absenteeism is rising. Productivity growth remains sluggish. I propose that it's not the idea of well-being that's failed; perhaps it's how we're defining and measuring success. The Paradox Of Progress Deloitte found that 81% of employers have increased their focus on mental health since the pandemic. But my company's 2025 well-being trends report found that while investment is up, outcomes are still flat. Just 17% of employees would be "very likely" to recommend their employer based on well-being. Most organizations are doing something about well-being. The question is: Are they doing the right things? Burnout is rising as job insecurity, economic pressures and an always-on work culture are taking their toll. People want flexible working, paid wellness days and healthcare. But in my experience, these only work when backed by a strong culture, consistent engagement and meaningful measurement. The Measurement Problem Too often, we confuse outputs with outcomes. It's natural to measure what's easy to track, but many of those metrics offer little insight into actual well-being. • Absenteeism is a lagging indicator—by the time it rises, it's already too late. • Employee assistance program (EAP) usage and gym subsidies mostly reflect those already proactive. • Annual engagement surveys can be skewed by recency bias or fatigue. These signals can lull leadership into thinking well-being is 'covered,' even while employees quietly struggle. Worse, they often miss the people who need support most, like carers, neurodiverse individuals or those managing chronic stress. I believe that if we stick to outdated metrics, we'll keep designing interventions that miss the mark. A New Well-Being Framework To succeed, we must stop treating well-being as a perk. It's not a policy—it's a culture. It needs to be woven into the everyday rhythms of work. To do this, I recommend adopting a model we use at my company called "everyday well-being." This model is based on small, consistent behaviors and supported by gamification, community and meaningful measurement. Gamification is central to this model—not as a gimmick, but as a behavioral science tool. It can help drive engagement through play, competition, purpose and habit formation rather than through pressure. When people enjoy a process, they are more likely to repeat it. Whether through step challenges, meditation streaks or team quests, you can help employees build healthy habits in ways that feel natural—and, yes, joyful. What To Measure Well-being should also be inclusive. It should reach all employees—remote or in-office, introvert or extrovert—and meet them where they are. That means tracking real-time behavioral signals, not just policy uptake. Here are a few of the metrics I've found to be the most useful for ensuring that well-being is embedded rather than just bolted onto your company culture: • Behavioral Micro-Metrics: Step counts, sleep streaks or hydration tracking can offer real insights into routine and resilience. • Challenge Participation: Engagement in team-based challenges can signal motivation, belonging and psychological safety, and I've found there to be a strong link between participation and employees' mood scores. • Mood Check-Ins: Real-time check-ins, via short prompts or surveys, can help flag patterns before they become problems. A slump in energy midweek? That may be a signal to act. • Recovery Rates: It's not just about stress—it's about bounce-back. In my experience, agency, community and supportive leadership can lead to quicker recoveries. • Cultural Signals: Does your leadership model well-being? Is it okay to log off at 5 p.m.? Culture can often determine whether team members' well-being is lived or just listed. Why Gamification Works Gamification is often misunderstood as fluff, but done right, it's a science-backed strategy for behavior change. Gamified environments drive higher habit formation and sustained engagement. In one trial done by my company, we found that users exposed to gamified features in our app were more than twice as likely to maintain new healthy behaviors. I believe this is because gamification isn't just about rewards—it taps into purpose, curiosity and community. Some users are motivated by leaderboards, others by quiet streaks or personal quests. That diversity is key, so ensure your gamification methods appeal to all types of "players." A Call To Business Leaders This is how we can go from reactive to proactive: not by waiting for people to reach burnout, but rather by helping them build resilience every day. If the first wave of your workplace well-being hasn't worked, it doesn't mean the idea has failed. It may just mean you've been using the wrong map. Don't abandon well-being because the first iteration didn't deliver what you hoped. Instead, take a step back and consider: Are you measuring the right things? Are you designing programs for real people with real constraints, not just the most engaged few? Are you embedding well-being into the flow of your team's work or bolting it on as an afterthought? It's time to refocus on long-term impact, better measurement and human-centered design. That means creating environments where small, daily actions lead to lasting change. Where technology supports rather than replaces human connection. And where culture reinforces rather than contradicts the message that well-being matters. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
